08162017Headline:

New York, New York

HomeNew YorkNew York

Roopal Luhana

Xarelto Linked to Over 20,000 Injuries in 2016: ISMP Report

As bellwether trials continue in the consolidated Xarelto Multidistrict litigation (“MDL”) pending in the U.S. District Court for the Eastern District of Louisiana, a new drug safety report highlights the dangerous side effects associated with the medication. Xarelto (rivaroxaban) is […]

Roopal Luhana

Invokana Doubles Risk of Lower-Limb Amputations: Study

The type 2 diabetes drug Invokana (canagliflozin) has been linked with some serious side effects, including kidney problems, urinary tract infections, and diabetic ketoacidosis. Now, according to recent studies, it may also double the risk for lower-limb amputation. Researchers presented […]

Eric T. Chaffin

New Report Raises Concerns About Actemra Side Effects

A new report by STAT News has raised new concerns about the rheumatoid arthritis (RA) drug Actemra and its link to serious cardiac injuries. In 2010, manufacturers Roche and subsidiary Genentech released Actemra for sale in the U.S. In their […]

Roopal Luhana

Xarelto Manufacturers Seek Approval for New Low-Dose Option

Xarelto manufacturer Janssen Research & Development LLC (and parent company Johnson & Johnson) recently announced that the FDA is reviewing a new low-dose version of the anticoagulant drug Xarelto. The announcement comes as the companies are defending against thousands of […]

Roopal Luhana

Many Patients Receiving the Wrong Dosage of Blood-Thinning Drug

Xarelto manufacturer Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J), has long advertised the new-generation blood thinner as being much more convenient than warfarin, the leading anticoagulant for decades because it doesn’t require blood monitoring. Patients taking warfarin are […]

Roopal Luhana

First Testosterone Bellwether Trial Ends in Mistrial

The first testosterone replacement therapy bellwether trial from the consolidated litigation in the Northern District of Illinois began on June 5, 2017. It ended in a mistrial only a few days later. According to a Notification of Docket Entry dated […]

Kendra Goldhirsch

North Carolina Plaintiff Joins Xarelto MDL

On May 3, 2017, a North Carolina woman filed a new Xarelto lawsuit against manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and Bayer AG. She joined the current Xarelto MDL underway in the Eastern District of Louisiana, where the […]

Kendra Goldhirsch

ISMP Warns About Risks of Combining Aspirin with Xarelto

As parties prepare for the second Xarelto bellwether trial in the Xarelto Multidistrict Litigation (MDL)in the Eastern District of Louisiana, the Institute of Safe Medication Practices (ISMP) has released their QuarterWatch report for the third quarter of 2016. Among the […]

Roopal Luhana

First AndroGel Bellwether Trial Set to Begin

The long-anticipated AndroGel bellwether trial is scheduled to begin on June 5, 2017. The case is the first to go to trial in the multidistrict litigation (MDL), which was established in June 2014, in the Northern District of Illinois. That […]

Roopal Luhana

First Testosterone Bellwether Trial Nears Starting Point

In March 2017, U.S. District Judge Matthew F. Kennelly met with the parties involved in the centralized testosterone replacement therapy (TRT) litigation to appoint a settlement master. The parties were instructed to attend monthly meetings to discuss potential settlement of […]